Introduction

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that causes fever, rash, and severe joint pain, particularly in tropical and subtropical regions. While the acute phase of the infection typically resolves within weeks, a significant proportion of patients experience chronic, repeated joint pain and inflammation that can last for months or even years. This chronic condition shares many similarities with autoimmune diseases, particularly rheumatoid arthritis (RA), raising questions about the relationship between CHIKV infection and autoimmune disorders. Studies suggest a correlation between CHIKV infection and the development of autoimmune diseases, warranting a comprehensive review of existing literature. This article reviews the immunological mechanisms underlying CHIKV infection, explores its association with autoimmune conditions, and discusses clinical implications based on recent studies.

Chikungunya virus overview

Occurrence of disease

Primarily, Aedes aegypti and Aedes albopictus mosquitoes spread CHIKV. Originally localised to tropical and subtropical regions of Africa and Asia, the virus has spread globally in recent decades, causing large outbreaks in the Americas, Europe, and the Pacific Islands.¹

Pathophysiology

CHIKV enters the body through mosquito bites, infecting susceptible cells in the skin, such as macrophages, fibroblasts, and endothelial cells. The virus then disseminates through the bloodstream to peripheral organs, including the liver, spleen, muscles, and joints.²

Mechanisms of CHIKV Pathogenesis

CHIKV infection triggers a robust immune response. The virus activates both innate and adaptive immunity, leading to the production of pro-inflammatory cytokines, such as IL-6, IL-1β, and TNF-α. This cytokine storm can contribute to tissue damage and inflammation, particularly in the joints. The prolonged inflammatory response may predispose individuals to autoimmune phenomena, as immune dysregulation can trigger self-reactive T cells and autoantibody production.

Common symptoms

The acute phase of CHIKV infection is characterised by:

• High fever
• Severe joint pain
• Muscle pain
• Headache
• Fatigue
• Rash

While most symptoms resolve within 1-2 weeks, joint pain can persist for months or years in some patients, leading to chronic chikungunya arthritis.³

Relationship between chikungunya and autoimmune diseases

Several studies have investigated the relationship between CHIKV infection and various autoimmune conditions:

Evidence of autoimmune responses

Rheumatoid Arthritis (RA): Evidence suggests that individuals with a history of CHIKV infection exhibit elevated levels of rheumatoid factor and anti-citrullinated protein antibodies, indicating a potential role of CHIKV in triggering RA or exacerbating pre-existing conditions.⁴ Studies have shown that CHIKV infection can trigger autoimmune-like responses in some individuals. Patients with chronic chikungunya arthritis often exhibit clinical and immunological features that overlap with those of RA patients.¹

Systemic Lupus Erythematosus (SLE): Some reports have linked CHIKV infection to the onset of SLE, particularly in genetically predisposed individuals. The presence of antinuclear antibodies following infection raises questions about the virus's role in immune system dysregulation.¹

Guillain-Barré Syndrome (GBS): A notable association has been observed between CHIKV and GBS, a post-infectious autoimmune neuropathy. Studies have reported increased incidences of GBS following CHIKV outbreaks, suggesting a potential molecular mimicry mechanism.⁶

Risk factors

Several factors have been associated with an increased risk of developing chronic chikungunya arthritis:

• Age >35-60 years
• AFAB (Assigned Female at Birth) gender
• Initial severe joint pain
• Pre-existing osteoarthritis
• High viral loads during the acute phase

Mechanisms of interaction

Inflammatory responses

CHIKV infection triggers a specialised innate immune response, characterised by strong activation of type 1 interferon and production of proinflammatory cytokines. This inflammatory cycle may contribute to the development of autoimmune-like conditions in vulnerable individuals.

Molecular mimicry

Molecular mimicry speculation between viral and host proteins may play a role in the development of autoimmune responses following CHIKV infection. However, more research is needed to confirm this hypothesis.¹

Repeated viral infections

Some studies have detected CHIKV RNA in synovial tissue of affected patients months after the initial infection, suggesting that repeated viral presence may contribute to chronic inflammation and autoimmune-like symptoms.

Inflammatory biomarkers play a significant role in indicating and potentially contributing to the severity of Chikungunya-related arthritis. Several key findings highlight their importance.

Biomarkers associated with disease severity

Acute phase

During the acute phase of Chikungunya infection, certain inflammatory markers have been linked with more severe disease.

• Increased levels of IL-1β and IL-6 were associated with higher fever, heart rate, and lower platelet counts^6,7
• Elevated levels of MIG, IP-10, and IgG correlated with more severe symptoms⁶

Chronic phase

In the chronic phase, characterised by repeated arthralgia and arthritis, several biomarkers remain elevated:

• IL-6, TNF-α, MCP-1, IL-12, and IFN-α levels were found to be increased in individuals with repeated polyarthralgia⁶
• IL-27, IL-17A, IL-29, and TGF-β were elevated in people in the subacute or chronic phase compared to healthy individuals⁶

Mechanisms and implications

Inflammatory cycle

The elevated levels of proinflammatory cytokines like IL-1β and IL-6 may contribute to the pathogenesis of arthritis:

• These cytokines are pyrogens, potentially responsible for high fever⁶
• They are involved in the development of arthralgia and are implicated in other forms of arthritis, such as rheumatoid arthritis⁶

T cell activation

Increased levels of certain chemokines may indicate ongoing immune activation:

• MIG and IP-10, induced by IFN-γ, regulate monocyte/macrophage migration and T cell activation⁶
• This repeated immune activation may contribute to chronic symptoms

Autoimmune-like features

The inflammatory profile in chronic Chikungunya arthritis shares similarities with autoimmune conditions:

• Patients with chronic Chikungunya arthritis exhibited a greater percentage of activated and effector CD4 and CD8 T cells, similar to rheumatoid arthritis patient¹
• Some patients with repeated symptoms met classification criteria for seronegative rheumatoid arthritis¹

Clinical utility

Monitoring these inflammatory biomarkers may have practical applications:

• They could help distinguish between mild disease and more severe forms of Chikungunya fever⁷
• Biomarkers, such as IL-6, IP-10, and CRP levels, have been associated with the persistence of musculoskeletal pain⁶

All in all, inflammatory biomarkers serve as important indicators of disease severity in Chikungunya-related arthritis. Their elevated levels not only reflect the intensity of the immune response but may also contribute to the pathogenesis of chronic arthritis. Understanding these biomarker profiles could aid in predicting disease course, guiding treatment decisions, and potentially developing targeted therapies for managing chronic Chikungunya arthritis.

Long-term consequences

Immunological changes

People with chronic chikungunya arthritis have been found to have a greater percentage of activated and effector CD4 and CD8 T cells compared to healthy controls, similar to RA patients.¹ A significant proportion of CHIKV-infected individuals develop a chronic, repeated rheumatic course that can mimic RA.¹ In one study, 8 out of 10 infected individuals developed chronic repeated rheumatic symptoms and met classification criteria for seronegative RA.¹

1. Induction of autoantibodies and rheumatic diseases

CHIKV infection can induce autoantibodies and rheumatic diseases such as rheumatoid arthritis (RA) and spondylarthritis.⁹ This suggests that the virus can trigger autoimmune responses in some individuals.

2. Potential for autoimmune disease emergence

There's a question of whether CHIKV infection could trigger the emergence of autoimmune diseases in genetically predisposed individuals under certain environmental conditions.³

3. Cytokine and chemokine profiles

CHIKV infection induces various cytokines and chemokines that are also implicated in autoimmune diseases. For example, IL-17A and IL-27 were found to be elevated in CHIKV patients and associated with joint symptoms.¹⁰

4. Chronic chikungunya arthritis

Approximately one-third of CHIKV-infected individuals develop chronic, repeated rheumatic symptoms that can last for months to years. In some cases, these patients meet the classification criteria for seronegative RA.¹ The chronic phase of CHIKV infection is characterised by repeated inflammation, which is a hallmark of many autoimmune diseases.^{10, 11}

These findings suggest a complex relationship between CHIKV infection and autoimmune diseases, with potential mechanisms including molecular mimicry, chronic inflammation, and shared immunological features. Further research is needed to fully understand these connections and their implications for diagnosis and treatment.

Ongoing research

Current research focuses on understanding the mechanisms underlying the transition from acute to chronic CHIKV infection and the potential role of host genetics in disease susceptibility and progression.⁴

Summary

The relationship between CHIKV infection and autoimmune diseases, particularly RA, is complex and not fully understood. While CHIKV infection can lead to chronic arthritis with features resembling autoimmune conditions, it remains unclear whether the virus directly triggers autoimmunity or exacerbates pre-existing susceptibilities.

Further research is needed to elucidate the precise mechanisms linking CHIKV infection to autoimmune-like conditions and to develop targeted therapies for managing chronic chikungunya arthritis. Understanding these connections is crucial for improving patient care and developing effective strategies for preventing and treating CHIKV-related chronic conditions.

FAQs

Q 1 - What is chikungunya fever?

Answer - Chikungunya fever is an illness caused by a virus spread by mosquito bites. The name means "bends you up" or "stooped walk" because it causes severe joint and muscle pain.

Q 2 - What are the main symptoms of chikungunya infection?

Answer - Common symptoms include:

• Sudden high fever
• Severe joint pain
• Muscle pain 
• Headache
• Fatigue
• Rash
• Nausea
• Red eyes

Q 3 - How long do symptoms last?

Answer - Many people recover within 1-2 weeks, but some may experience joint pain that lasts for months or even years.

Q 4 - Is the chikungunya virus associated with autoimmune diseases?

Answer - Chikungunya virus (CHIKV) infection has been associated with the development of autoimmune-like conditions in some patients:

• CHIKV can induce autoantibodies and rheumatic diseases such as rheumatoid arthritis (RA) and spondylarthritis.⁸
• Some patients develop a chronic, repeated course of musculoskeletal disease that overlaps clinically and immunologically with RA.¹
• There is a case report of Sjögren's syndrome developing in association with CHIKV infection.⁸

However, the exact relationship between CHIKV and autoimmune diseases is still being studied. While CHIKV can trigger autoimmune-like symptoms, there is no clear evidence that it directly causes autoimmune diseases.¹²

Q 5 - Can chikungunya virus trigger other autoimmune conditions?

There is some evidence that CHIKV may be associated with other autoimmune-like conditions:

• A case report describes Sjögren's syndrome, which develops in association with CHIKV infection⁸
• CHIKV infection can induce autoantibodies, like antinuclear antibodies (ANAs)¹
• The virus shares some peptide sequences with autoantigens involved in Sjögren's syndrome, suggesting potential molecular mimicry⁸

However, to fully understand the relationship between CHIKV and various autoimmune conditions, more research is needed.

Q 6 - Can chikungunya virus infection affect the immune system long-term?

Answer - CHIKV infection may have some long-term effects on the immune system:

• It can alter CD8 T cell trafficking and compromise lymph node function in animal studies¹²
• Chronic inflammation may persist in some patients even after viral clearance²
• The virus may induce autoantibody production¹

However, the full extent of long-term immune system effects is still being investigated. More research is needed to understand the immunological consequences of CHIKV infection.²